{"result": "(\"entity\"<|>LIVER CIRRHOSIS<|>EVENT<|>Liver cirrhosis is a chronic liver disease characterized by the replacement of healthy liver tissue with scar tissue, leading to liver dysfunction and various complications.)\n##\n(\"entity\"<|>EUROPEAN SOCIETY OF PARENTERAL AND ENTERAL NUTRITION<|>ORGANIZATION<|>The European Society of Parenteral and Enteral Nutrition is an organization focused on improving nutritional care for patients, particularly those requiring parenteral and enteral nutrition.)\n##\n(\"entity\"<|>MAYO CLINIC<|>ORGANIZATION<|>Mayo Clinic is a nonprofit American academic medical center that provides clinical practice, education, and research in various medical fields, including liver disease.)\n##\n(\"entity\"<|>NUTRITION<|>EVENT<|>Nutrition refers to the process of providing or obtaining the food necessary for health and growth, which is critical for patients with liver cirrhosis.)\n##\n(\"entity\"<|>NUTRITIONAL STATUS<|>EVENT<|>Nutritional status is a measure of the health of individuals based on their dietary intake and nutritional needs, particularly important in patients with liver cirrhosis.)\n##\n(\"entity\"<|>DIABETES<|>EVENT<|>Diabetes is a chronic condition that affects how the body processes blood sugar (glucose), and it has prognostic significance in patients with liver cirrhosis.)\n##\n(\"entity\"<|>GLUCOSE UPTAKE<|>EVENT<|>Glucose uptake refers to the process by which cells absorb glucose from the bloodstream, which can be impaired in patients with liver cirrhosis.)\n##\n(\"entity\"<|>PROTEIN-CALORIE MALNUTRITION<|>EVENT<|>Protein-calorie malnutrition is a condition resulting from inadequate intake of protein and calories, often seen in patients with liver cirrhosis.)\n##\n(\"entity\"<|>HOSPITALIZED PATIENTS<|>PERSON<|>Hospitalized patients are individuals receiving medical care in a hospital, often including those with liver cirrhosis.)\n##\n(\"relationship\"<|>LIVER CIRRHOSIS<|>NUTRITION<|>Nutrition is critical for managing liver cirrhosis and improving patient outcomes<|>8)\n##\n(\"relationship\"<|>LIVER CIRRHOSIS<|>NUTRITIONAL STATUS<|>Nutritional status is an important factor in the prognosis and management of liver cirrhosis<|>7)\n##\n(\"relationship\"<|>LIVER CIRRHOSIS<|>DIABETES<|>Diabetes has a significant impact on the health outcomes of patients with liver cirrhosis<|>6)\n##\n(\"relationship\"<|>LIVER CIRRHOSIS<|>GLUCOSE UPTAKE<|>Impaired glucose uptake is a common issue in patients with liver cirrhosis<|>6)\n##\n(\"relationship\"<|>LIVER CIRRHOSIS<|>PROTEIN-CALORIE MALNUTRITION<|>Protein-calorie malnutrition is a frequent complication in patients with liver cirrhosis<|>7)\n##\n(\"relationship\"<|>EUROPEAN SOCIETY OF PARENTERAL AND ENTERAL NUTRITION<|>MAYO CLINIC<|>Both organizations are involved in improving nutritional care for patients, including those with liver cirrhosis<|>5)\n##\n(\"relationship\"<|>HOSPITALIZED PATIENTS<|>LIVER CIRRHOSIS<|>Hospitalized patients often include those suffering from liver cirrhosis<|>8)\n<|COMPLETE|>", "input": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: survived the first year after transplanta-                  ism. Alcohol Clin Exp Res 2001; 25:83-88.\n      tion. J Gastroenterol Hepatol. 2010; 25(2):391-6.                 36.  Testa R, Franceschini R, Giannini E, et al.               Serum\n21.   Lautz H U, Selberg O, Körber J, Bürger M, Müller                       leptin levels in patients with viral chronic hepatitis\n      M J. Protein calorie malnutrition in liver cirrhosis.                  or liver cirrhosis. J Hepatol 2000; 33:33-37.\n      Clin Invest 1992;70:478-486.                                      37.  Greco AV, Mingrone G, Favuzzi A,                 et al.   Serum\n22.   Sam J, Nguyen GC. Protein-calorie malnutrition as                      leptin levels in post-hepatitis liver cirrhosis. J Hepa-\n      a prognostic indicator of mortality among patients                     tol 2000; 33:38-42.\n      hospitalized with cirrhosis and portal hyperten-                  38.  Onodera K, Kato A, Suzuki K. Serum leptin con-\n      sion. Liver Int. 2009; 29(9):1396-402.                                 centrations in liver cirrhosis: relationship to the\n23.   Marsano L, McClain CJ. Nutrition and alcoholic liv-                    severity of liver dysfunction and their characteristic\n      er disease. JPEN 1991;15:337-344.                                      diurnal      profiles.    Hepatology        Research      2001;\n24.   Figueiredo FA, Perez RM, Freitas MM, et al. Com-                       21:205-212.\n      parison of three methods of nutritional assess-                   39.  Ockenga J, Bischoff SC, Tillmann HL, et al. Elevated\n      ment in liver cirrhosis: subjective global assess-                     bound leptin correlates with energy expenditure in\n      ment, traditional nutritional parameters, and body                     cirrhotics. Gastroenterology 2000; 119:1656-1662.\n      composition        analysis.     J  Gastroenterol.       2006;    40.  Romiti A, Merli M, Martorano M, et al. Malabsorp-\n      41(5):476-82.                                                          tion and nutritional abnormalities in patients with\n25.   Lochs H, Plauth M. Liver cirrhosis: Rationale and                      liver cirrhosis. Ital J Gastroenterol 1990;22:118.\n      modalities for nutritional support—the European                   41.  Plauth M, Schütz ET. Cachexia in liver cirrhosis. Int.\n      Society of Parenteral and Enteral Nutrition consen-                    J. Cardiol.2002; 85: 83-7.\n      sus and beyond. Curr Opin Clin Nutr Metab Care                    42.  Muller MJ, Pirlich M, Balks HJ, et al. Glucose intol-\n      2:345-349, 1999                                                        erance     in   liver  cirrhosis:    Role    of  hepatic     and\n26.   DiCecco SR, Wieners EJ, Wiesner RH, et al. Assess-                     non-hepatic influences. Eur J Clin Chem Clin Bio-\n      ment of nutritional status of patients with end-                       chem 1994 ;32:749-758.\n      stage liver disease undergoing liver transplanta-                 43.  Bianchi G, Marchesini G, Zoli M, Bugianesi E, Fab-\n      tion. Mayo Clin Proc 1989;64(1):95-102.                                bri A, Pisi E. Prognostic significance of diabetes in\n27.   Alberino F, Gatta A, Amidio P, et al. Nutrition and                    patients with cirrhosis. Hepatology 1994; 20:119-\n      survival in patients with liver cirrhosis. Nutrition                   125.\n      2001;17:445-50.                                                   44.  Imano E, Kanda T, Nakatani Y. Impaired splanch-\n28.   Ferreira LG, Ferreira Martins AI, Cunha CE,               et al.       nic and peripheral glucose uptake in liver cirrhosis.\n      Negative energy balance secondary to inadequate                        J Hepatol 1999; 31:469-73.\n      dietary intake of patients on the waiting list for liv-           45.  Changani KK, Jalan R, Cox IJ,            et al.   Evidence for\n      er transplantation. Nutrition. 2013;29(10):1252-8.                     altered hepatic gluconeogenesis in patients with\n29.   Madden AM, Bradbury W, Morgan MY. Taste per-                           cirrhosis using in vivo 31-phosphorus magnetic\n      ception in cirrhosis: its relationship to circulating                  resonance spectroscopy. Gut 2001; 49:557-564.\n      micronutrients and food preferences. Hepatology                   46.  Owen OE, Trapp VE, Reichard Jr GA, et al. Nature\n      1997; 26:40.                                                           and quantity of fuels consumed in patients with al-\n30.   Davidson HIM, Richardson R, Sutherland D, Gar-                         coholic cirrhosis. J Clin Invest 198\n######################\nOutput:", "parameters": {"model": "gpt-4o-mini", "temperature": 0.0, "frequency_penalty": 0.0, "presence_penalty": 0.0, "top_p": 1.0, "max_tokens": 4000, "n": 1}, "history": null}